Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.32 | 182.04 |
| PEG Ratio (TTM) | 0.08 | -2.97 |
| P/S Ratio (TTM) | 2.84 | 8.39 |
| P/B Ratio (TTM) | 0.74 | 2.23 |
| P/FCF Ratio (TTM) | 3.65 | -86.52 |
| Price to 5YR AVG Earnings Ratio | N/A | 24.34 |
| Price to 5YR AVG FCF Ratio | N/A | -285.94 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -21.50% | 0.75% |
| ROE (TTM) | -30.35% | 1.86% |
| Net Profit Margin (TTM) | -122.37% | 6.31% |
| ROIC 5YR AVG | N/A | 2.49% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1,353.86% | 11.36% | N/A |
| Revenue | -7.01% | 1.15% | N/A |
| Net Income | -1,359.70% | 11.30% | N/A |
| Cash Flow | 43.68% | 11.24% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.95 | 7.19 |
| Quick Ratio (TTM) | 1.95 | 7.19 |
| D/E Ratio (TTM) | 0.38 | 1.04 |
| Interest Coverage (TTM) | 0.28 | 1.89 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.44 | 1.31 |
| LTL to 5YR AVG FCF | N/A | -89.83 |
| Shares Outstanding Growth 5YR AVG | N/A | 5.84% |